Related Experiment Video

Updated: Jun 14, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Baqiyyah Conway1, Tina Costacou, Trevor Orchard

  • 1University of Pittsburgh, Department of Epidemiology, 3512 Fifth Avenue, Pittsburgh, PA 15217, USA.

Diabetes & Vascular Disease Research
|April 7, 2010
PubMed

Insights

Glycemic control (HbA1c) predicts fatal coronary artery disease (CAD) in type 1 diabetes (T1D). However, lower insulin doses and traditional risk factors predict non-fatal CAD events in T1D patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetes Research

Background:

  • Coronary artery disease (CAD) is a primary cause of mortality in type 1 diabetes (T1D).
  • The precise mechanisms driving elevated CAD risk in T1D remain unclear, with ongoing debate regarding the role of glycemic control.
  • Existing research presents conflicting findings on whether glycemic control predicts CAD incidence versus mortality.

Purpose of the Study:

  • To investigate differential risk factors for CAD morbidity and mortality in a type 1 diabetes cohort.
  • To specifically analyze the influence of HbA1c and insulin dose on CAD outcomes.
  • To clarify the role of glycemic control in the context of other established cardiovascular risk factors.

Main Methods:

  • Analysis of the Pittsburgh Epidemiology of Diabetes Complications study cohort.
  • Longitudinal follow-up of 592 T1D participants for 18 years, recording incident non-fatal and fatal CAD events.
  • Utilized Cox stepwise regression to identify independent risk factors for both non-fatal and fatal CAD.

Main Results:

  • Baseline HbA1c emerged as an independent predictor of fatal CAD, alongside diabetes duration and albuminuria.
  • Conversely, a lower baseline insulin dose strongly predicted non-fatal CAD.
  • Other significant predictors for non-fatal CAD included reduced renal function, elevated diastolic blood pressure, and adverse lipid profiles.

Conclusions:

  • Glycemic control, specifically HbA1c levels, is a significant predictor of fatal coronary artery disease in individuals with type 1 diabetes.
  • Non-fatal CAD events in T1D are more strongly associated with lower insulin doses and conventional cardiovascular risk factors.
  • These findings highlight distinct pathophysiological pathways for CAD morbidity and mortality in type 1 diabetes, emphasizing the need for tailored risk management strategies.

More Related Videos

Isolation of Human Islets from Partially Pancreatectomized Patients11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...